Early tests for two drugs for bleeding Ebola fever have shown great efficacy and, according to scientists, can save many people. US involved in tests Informed the Reuters, citing the National Institute for Allergies and Infectious Diseases (NIAID).
The Congo was hit by the outbreak of the Ebola outbreak, where 1,800 people died in a single year, according to the World Health Organization (WHO), a highly contagious virus in half of cases.
Four drugs have been tested in Congo and two have proven extremely effective. NIAID treats the results very well. These preparations will now be given to all infected people in the Congo.
Two out of four #Ebola Drugs are being investigated #DRC, Has been shown to be more effective. They are the ones that will be used with future patients. Https://t.co/Jcq97oP55t pic.twitter.com/H96wcwG2CI
– World Health Organization (WHO) August 12, 2019
The effective drugs designated as Regnat-EB3 and MAB114 in tests show that they are capable of neutralizing the effect of the virus on the body's cells. "This is the first drug in which scientific studies have significantly reduced mortality in Ebola patients," said NIAID Director Anthony Fousi.
Is there a new epidemic? Ebola kills already in Uganda, the assembly is banned somewhere
Both preparations were developed using antibodies taken from Ebola survivors. The other two drugs were excluded from the study because they proved ineffective.
Last November, scientific tests began under the leadership of the WHO. Since then, 700 patients have received experimental medicine and the results are still in 499 of them. Of the Regno-EB3 group, 29 percent of patients died, and 34 percent in the MAB 114 group. For two embedded substances, the mortality was 49 and 53 percent.
Survival rates in patients with low blood virus levels were up to 94 percent with Regnat-EB3 and 89 percent with MAB 114.
Sabu Mulangi, an infectious disease expert who participated in the study, said the results emphasize to authorities that early treatment has a 90% chance of survival.
Jeremy Farrar, director of the Wellcome Trust, said research shows that preparation for the test can save lives and the world is approaching a time when Ebola can be cured. "We will not get rid of it, but we must be able to prevent national and regional epidemics," he said.
Huawei introduced its vision for the future. 10 megatrends to avoid (photo)